Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Linn Hodneland Nilsson"'
Autor:
Olav Tenstad, Eleni Christakou, Linn Hodneland Nilsson, Gro Gausdal, David Micklem, Petri Kursula, James B. Lorens, Rolf K. Reed
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Soluble biomarkers are paramount to personalized medicine. However, the in vivo turnover and biodistribution of soluble proteins is seldom characterized. The cleaved extracellular domain of the AXL receptor (sAXL) is a prognostic biomarker i
Externí odkaz:
https://doaj.org/article/7cd00871860a442ab5032350c2e15f75
Autor:
Sturla Magnus Grøndal, Linn Hodneland Nilsson, Magnus Blø, Anna Boniecka, Eline Milde, Akil Jackson, Gro Gausdal, James B Lorens
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Renal fibrosis, a progressive process of extracellular matrix accumulation leading to renal failure, lacks effective treatment. Expression of the AXL receptor tyrosine kinase has been implicated in kidney injury and mesangial prol
Autor:
Magnus Blø, Linn Hodneland Nilsson, James B. Lorens, Akil Jackson, Lea Landolt, A. Boniecka, Gro Gausdal, Tarig Al-Hadi Osman, Hans-Peter Marti, Sturla Magnus Grøndal, Barbara VanderHoeven, David Micklem
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Interstitial fibrosis, characterised by the accumulation of extracellular matrix in the cortical interstitium, is directly correlated with progressive chronic kidney disease secondary to inflammatory, immunologic, obstructive or m
Autor:
Werner J.H. Koopman, Fredrik Hoel, Peter H.G.M. Willems, Linn Hodneland Nilsson, Sander Grefte, Julie Nikolaisen, Ina Katrine Nitschke Pettersen, Karl Johan Tronstad, Maciek Sokolewicz, Marco Nooteboom, Sissel E. Dyrstad
Publikováno v:
Current Pharmaceutical Design, 20, 35, pp. 5634-52
ResearcherID
Current pharmaceutical design
Current Pharmaceutical Design, 20, 5634-52
ResearcherID
Current pharmaceutical design
Current Pharmaceutical Design, 20, 5634-52
Item does not contain fulltext Mitochondria play a key role in signal transduction, redox homeostasis and cell survival, which extends far beyond their classical functioning in ATP production and energy metabolism. In living cells, mitochondrial cont
Autor:
Karl Johan Tronstad, Julie Nikolaisen, Linn Hodneland Nilsson, Lena Burri, Hanne R. Hagland, Rolf K. Berge
Publikováno v:
Biochemical and Biophysical Research Communications-BBRC
The hypolipidemic effect of peroxisome proliferator-activated receptor (PPAR) activators has been explained by increasing mitochondrial fatty acid oxidation, as observed in livers of rats treated with the pan-PPAR activator tetradecylthioacetic acid
Autor:
Julie Nikolaisen, Linn Hodneland Nilsson, David Micklem, Karl Johan Tronstad, Ina Katrine Nitschke Pettersen, Gro V. Røsland, Hege Avsnes Dale, James B. Lorens
Publikováno v:
Scientific Reports. 6
Scientific Reports 5: Article number: 17217; published online: 24 November 2015; updated: 19 August 2016. This Article contains errors in Figure 4. In Figure 4B, the y-axis ‘V m,cell (µm3)’ is incorrectly labelled as ‘V m,cell (m3)’. In Figu
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1817:S70